Back to top
more

Ingevity (NGVT)

(Delayed Data from NYSE)

$48.51 USD

48.51
146,152

+0.64 (1.34%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $48.49 -0.02 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (79 out of 252)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NGVT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Ingevity Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 96 77 275 258 57
Receivables 182 225 162 148 150
Notes Receivable 0 0 0 0 0
Inventories 309 335 241 189 213
Other Current Assets 72 43 47 34 44
Total Current Assets 659 679 725 629 463
Net Property & Equipment 762 799 720 704 665
Investments & Advances 178 188 76 74 73
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 12 6 7 8 5
Intangibles 864 923 780 819 833
Deposits & Other Assets 82 86 110 53 50
Total Assets 2,623 2,737 2,469 2,335 2,142
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 84 1 20 26 23
Accounts Payable 158 175 126 104 99
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 92 108 100 72 62
Income Taxes Payable 9 4 6 5 15
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 363 304 269 223 216
Mortgages 0 0 0 0 0
Deferred Taxes/Income 71 107 115 117 100
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,383 1,473 1,250 1,267 1,228
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 127 115 126 50 30
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,992 2,038 1,795 1,692 1,611
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 165 153 136 121 113
Retained Earnings 1,002 1,008 796 678 497
Other Equity -27 -47 13 5 -5
Treasury Stock 510 416 272 162 75
Total Shareholder's Equity 631 698 674 642 531
Total Liabilities & Shareholder's Equity 2,623 2,737 2,469 2,335 2,142
Total Common Equity 631 698 674 642 531
Shares Outstanding 36.20 37.30 39.20 41.20 41.80
Book Value Per Share 17.44 18.72 17.19 15.58 12.70

Fiscal Year End for Ingevity Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 96 85 68 78
Receivables NA 182 217 260 240
Notes Receivable NA 0 0 0 0
Inventories NA 309 387 387 361
Other Current Assets NA 72 47 50 37
Total Current Assets NA 659 735 764 716
Net Property & Equipment NA 762 800 801 805
Investments & Advances NA 178 180 179 178
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 12 6 7 7
Intangibles NA 864 896 921 921
Deposits & Other Assets NA 82 82 90 89
Total Assets NA 2,623 2,767 2,828 2,772
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 84 3 1 1
Accounts Payable NA 158 197 204 174
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 92 81 84 76
Income Taxes Payable NA 9 5 5 11
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 363 305 311 279
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 71 105 110 108
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,383 1,470 1,526 1,503
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 118 119 117
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,992 2,048 2,114 2,047
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 165 163 164 159
Retained Earnings NA 1,002 1,119 1,094 1,058
Other Equity NA -27 -54 -34 -39
Treasury Stock NA 510 510 510 453
Total Shareholder's Equity NA 631 719 714 726
Total Liabilities & Shareholder's Equity NA 2,623 2,767 2,828 2,772
Total Common Equity 0 631 719 714 726
Shares Outstanding 36.20 36.20 36.20 36.30 37.10
Book Value Per Share 0.00 17.44 19.85 19.67 19.56